IP Library Granted Patent US 12,280,024
Granted Patent B2
US 12,280,024 · App. 18/477,161 · Granted Apr 22, 2025

Epinephrine formulations

Inventors: Suketu Sanghvi (Kendall Park, NJ); Vinayagam Kannan (Morris Plains, NJ); Matthew Kenney (New Haven, MI)
Assignee: ENDO OPERATIONS LIMITED
A61K31/137A61K9/0019A61K9/08A61K47/12A61K47/20A61K9/0014A61K9/0048A61K9/0073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,024
App. No.
18/477,161
Granted
Apr 22, 2025
Kind
B2
Abstract

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.

Claims (12)

1. A composition comprising:

in the range of about 0.75 to 1.25 mg/mL of epinephrine and/or salts thereof,

in the range of about 6 to 8 mg/mL of a tonicity regulating agent,

in the range of 2 and 15 mg/mL of tartaric acid,

in the range of 1 and 5 mg/mL of sodium hydroxide,

in the range of about 0.4 and 0.5 mg/mL of an antioxidant,

in the range of about 0.001 to 0.010 mL/mL of a pH lowering agent,

wherein the antioxidant comprises sodium bisulfite and/or sodium metabisulfite, and

wherein the composition comprises about 3% or less total impurities after 6 months of storage at between 23° C. and 32° C. and between 55% RH and 70% RH.

2. The composition of claim 1 , wherein the tonicity regulating agent comprises sodium chloride.

3. The composition of claim 1 , wherein the pH lowering agent comprises hydrochloric acid.

4. The composition of claim 1 , further comprising a solvent.

Assignments (8)
SHORT FORM INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 6, 2025
From: PH HEALTH LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 073508/0830 →
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (068461/0692) Recorded Aug 4, 2025
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: ENDO OPERATIONS LIMITED
Reel/Frame 072343/0897 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2025
From: ENDO OPERATIONS LIMITED
To: PH HEALTH LIMITED
Reel/Frame 072131/0540 →
SECURITY INTEREST Recorded Jul 22, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068469/0001 →
SECURITY INTEREST Recorded Jul 19, 2024
From: ENDO BIOLOGICS LIMITED; ENDO OPERATIONS LIMITED
To: GOLDMAN SACHS BANK USA
Reel/Frame 068461/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2024
From: ENDO USA, INC.
To: ENDO OPERATIONS LIMITED
Reel/Frame 067245/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2024
From: PAR PHARMACEUTICAL, INC.
To: ENDO USA, INC.
Reel/Frame 067203/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2023
From: SANGHVI, SUKETU; KANNAN, VINAYAGAM; KENNEY, MATTHEW
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 065095/0638 →